Goldsmith D - Search Results

1

Magnesium in chronic kidney disease: challenges and opportunities.

Kanbay M, Goldsmith D, Uyar ME, Turgut F, Covic A. Kanbay M, et al. Among authors: goldsmith d. Blood Purif. 2010;29(3):280-92. doi: 10.1159/000276665. Epub 2010 Jan 21. Blood Purif. 2010. PMID: 20090315 Review.

2

Sodium thiosulfate: new hope for the treatment of calciphylaxis.

Hayden MR, Goldsmith DJ. Hayden MR, et al. Semin Dial. 2010 May-Jun;23(3):258-62. doi: 10.1111/j.1525-139X.2010.00738.x. Semin Dial. 2010. PMID: 20636917 Review.

3

Page kidney--a review of the literature.

Haydar A, Bakri RS, Prime M, Goldsmith DJ. Haydar A, et al. J Nephrol. 2003 May-Jun;16(3):329-33. J Nephrol. 2003. PMID: 12832730 Review.

4

Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease.

Sinha MD, Turner C, Booth CJ, Waller S, Rasmussen P, Goldsmith DJ, Simpson JM. Sinha MD, et al. Among authors: goldsmith dj. Pediatr Nephrol. 2015 Oct;30(10):1843-52. doi: 10.1007/s00467-015-3125-3. Epub 2015 May 15. Pediatr Nephrol. 2015. PMID: 25975437

5

Statins in chronic kidney disease and kidney transplantation.

Kassimatis TI, Goldsmith DJ. Kassimatis TI, et al. Pharmacol Res. 2014 Oct;88:62-73. doi: 10.1016/j.phrs.2014.06.011. Epub 2014 Jul 1. Pharmacol Res. 2014. PMID: 24995940 Review.

6

Mineral metabolism and vitamin D in chronic kidney disease--more questions than answers.

Goldsmith DJ, Cunningham J. Goldsmith DJ, et al. Nat Rev Nephrol. 2011 Jun;7(6):341-6. doi: 10.1038/nrneph.2011.53. Epub 2011 May 3. Nat Rev Nephrol. 2011. PMID: 21537350 Review.

7

Hemoglobin normalization trials in chronic kidney disease: what should we learn about quality of life as an end point?

Covic A, Seica A, Gusbeth-Tatomir P, Goldsmith D. Covic A, et al. Among authors: goldsmith d. J Nephrol. 2008 Jul-Aug;21(4):478-84. J Nephrol. 2008. PMID: 18651536 Review.

8

The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).

O'Flaherty D, Sankaralingam A, Scully P, Manghat P, Goldsmith D, Hampson G. O'Flaherty D, et al. Among authors: goldsmith d. Clin Biochem. 2013 Oct;46(15):1405-9. doi: 10.1016/j.clinbiochem.2013.06.023. Epub 2013 Jul 2. Clin Biochem. 2013. PMID: 23830844

9

Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD).

Manghat P, Souleimanova I, Cheung J, Wierzbicki AS, Harrington DJ, Shearer MJ, Chowienczyk P, Fogelman I, Nerlander M, Goldsmith D, Hampson G. Manghat P, et al. Among authors: goldsmith d. Bone. 2011 May 1;48(5):1127-32. doi: 10.1016/j.bone.2011.01.016. Epub 2011 Jan 31. Bone. 2011. PMID: 21281749

10

The EVOLVE study is negative, so what does this 'bitter pill' of disappointment mean now for renal patients?

Goldsmith D, Covic A. Goldsmith D, et al. Int J Clin Pract. 2014 Mar;68(3):286-9. doi: 10.1111/ijcp.12261. Int J Clin Pract. 2014. PMID: 24588948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results